Boltwood Capital Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,197
| Closed | -$232K | – | 171 |
|
|
2024
Q3 | $232K | Sell |
1,197
-7
| -0.6% | -$1.36K | 0.07% | 157 |
|
|
2024
Q2 | $279K | Sell |
1,204
-56
| -4% | -$13K | 0.09% | 147 |
|
|
2024
Q1 | $272K | Buy |
1,260
+13
| +1% | +$2.8K | 0.08% | 150 |
|
|
2023
Q4 | $323K | Sell |
1,247
-10
| -0.8% | -$2.59K | 0.11% | 138 |
|
|
2023
Q3 | $323K | Sell |
1,257
-11
| -0.9% | -$2.83K | 0.12% | 124 |
|
|
2023
Q2 | $361K | Sell |
1,268
-20
| -2% | -$5.7K | 0.13% | 125 |
|
|
2023
Q1 | $358K | Sell |
1,288
-2
| -0.2% | -$556 | 0.13% | 121 |
|
|
2022
Q4 | $357K | Sell |
1,290
-27
| -2% | -$7.48K | 0.15% | 117 |
|
|
2022
Q3 | $352K | Buy |
1,317
+60
| +5% | +$16K | 0.16% | 114 |
|
|
2022
Q2 | $256K | Buy |
+1,257
| New | +$256K | 0.11% | 135 |
|
|
2019
Q2 | – | Sell |
-2,116
| Closed | -$500K | – | 129 |
|
|
2019
Q1 | $500K | Buy |
2,116
+129
| +6% | +$30.5K | 0.33% | 89 |
|
|
2018
Q4 | $597K | Sell |
1,987
-39
| -2% | -$11.7K | 0.41% | 78 |
|
|
2018
Q3 | $715K | Buy |
2,026
+37
| +2% | +$13.1K | 0.43% | 84 |
|
|
2018
Q2 | $577K | Buy |
1,989
+45
| +2% | +$13.1K | 0.38% | 87 |
|
|
2018
Q1 | $532K | Sell |
1,944
-41
| -2% | -$11.2K | 0.36% | 86 |
|
|
2017
Q4 | $632K | Sell |
1,985
-625
| -24% | -$199K | 0.39% | 79 |
|
|
2017
Q3 | $817K | Buy |
2,610
+50
| +2% | +$15.7K | 0.53% | 64 |
|
|
2017
Q2 | $694K | Buy |
2,560
+100
| +4% | +$27.1K | 0.47% | 70 |
|
|
2017
Q1 | $672K | Buy |
2,460
+380
| +18% | +$104K | 0.47% | 71 |
|
|
2016
Q4 | $589K | Sell |
2,080
-20
| -1% | -$5.66K | 0.45% | 75 |
|
|
2016
Q3 | $657K | Buy |
2,100
+55
| +3% | +$17.2K | 0.53% | 64 |
|
|
2016
Q2 | $495K | Buy |
2,045
+125
| +7% | +$30.3K | 0.41% | 74 |
|
|
2016
Q1 | $500K | Buy |
+1,920
| New | +$500K | 0.44% | 73 |
|